Kyndrisa

The Woman Behind Sarepta Therapeutics' Success
Motley Fool
Mon, 09/26/16 - 09:38 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Kyndrisa
FDA
Janet Woodcock
Sarepta quickly lays out manufacturing, launch plans after delayed approval of Duchenne MD drug
Fierce Pharma
Sat, 09/24/16 - 01:32 pm
Sarepta Therapeutics
Kyndrisa
Duchenne Muscular Dystrophy
FDA approval in hand, Sarepta plans for future studies
BioPharma Dive
Fri, 09/23/16 - 09:44 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Kyndrisa
After Sarepta win, BioMarin appeals DMD patent ruling
BioPharma Dive
Fri, 09/23/16 - 09:35 am
Sarepta Therapeutics
Biomarin
patents
Duchenne Muscular Dystrophy
eteplirsen
Kyndrisa
Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD
Investors.com
Fri, 07/15/16 - 10:15 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
Raxone
Kyndrisa
Santhera
Why BioMarin's Shares Tumbled 11% in June
Motley Fool
Sun, 07/10/16 - 12:09 pm
Biomarin
M&A
Duchenne Muscular Dystrophy
Sanofi
drisapersen
Kyndrisa
BioMarin to Stop Developing its Duchenne Muscle Disease Drug
Bloomberg
Tue, 05/31/16 - 09:56 pm
Biomarin
Duchenne Muscular Dystrophy
Kyndrisa
3 Biotech Stocks Buoyed By Potential Blockbuster Drugs
Investors.com
Sat, 05/7/16 - 01:13 pm
JCAR015
Juno Therapeutics
Kyndrisa
Biomarin
Intercept Pharma
Ocaliva
BioMarin Fails to Win Approval for Drug to Treat Deadly Duchenne
Bloomberg
Thu, 01/14/16 - 10:07 am
Biomarin
FDA
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen
BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date
Yahoo
Fri, 12/18/15 - 09:07 am
Biomarin
FDA
drisapersen
Kyndrisa
Duchenne Muscular Dystrophy
FDA Committee Raises Concerns about Kyndrisa’s Efficacy, Safety
Yahoo/Market Realist
Fri, 12/11/15 - 10:27 pm
FDA
Kyndrisa
Duchenne Muscular Dystrophy
Biomarin
drisapersen
BioMarin: So You’re Saying There’s a Chance?
Barron's
Wed, 11/25/15 - 11:31 am
Biomarin
Duchenne Muscular Dystrophy
drisapersen
Kyndrisa
FDA
​The first drug for Duchenne will be reviewed at the FDA today: Why it matters
Bizjournals.com
Tue, 11/24/15 - 09:51 am
FDA
Biomarin
advisory panels
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen